Market Value2,795,946,341
Total Holdings70
File Date2024-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CRL / Charles River Laboratories International, Inc.
MDVLQ / MedAvail Holdings, Inc.
RGNX / REGENXBIO Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
ACIU / AC Immune SA
NRIX / Nurix Therapeutics, Inc.
SYK / Stryker Corporation
TRDA / Entrada Therapeutics, Inc.
ALLK / Allakos Inc.
IMGN / ImmunoGen, Inc.
EVH / Evolent Health, Inc.
AUGX / Augmedix, Inc.
LSAQ / LifeSci Acquisition II Corp
NVTA / Invitae Corporation
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
ABT / Abbott Laboratories
SONX / Sonendo, Inc.
CUTR / Cutera, Inc.
DXCM / DexCom, Inc.
RYZB / RayzeBio, Inc.
XENE / Xenon Pharmaceuticals Inc.
CABA / Cabaletta Bio, Inc.
SRRK / Scholar Rock Holding Corporation
FATE / Fate Therapeutics, Inc.
GRTSQ / Gritstone bio, Inc.
SLGC / Standard BioTools Inc.
BCEL / Atreca, Inc.
LVTX / LAVA Therapeutics N.V.
XERS / Xeris Biopharma Holdings, Inc.
NGNE / Neurogene Inc.
ABSI / Absci Corporation
PEN / Penumbra, Inc.
LIVN / LivaNova PLC
AKRO / Akero Therapeutics, Inc.
ANNX / Annexon, Inc.
CLDX / Celldex Therapeutics, Inc.
KRYS / Krystal Biotech, Inc.
FOLD / Amicus Therapeutics, Inc.
US64049K2033 / Neoleukin Therapeutics, Inc.
STTK / Shattuck Labs, Inc.
TKNO / Alpha Teknova, Inc.
ETNB / 89bio, Inc.
COGT / Cogent Biosciences, Inc.
HUM / Humana Inc.
IMVT / Immunovant, Inc.
BHVN / Biohaven Ltd.
ADCT / ADC Therapeutics SA
PLRX / Pliant Therapeutics, Inc.
HCA / HCA Healthcare, Inc.
ALGN / Align Technology, Inc.
ELV / Elevance Health, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
VERV / Verve Therapeutics, Inc.
ALXO / ALX Oncology Holdings Inc.
SPY / SPDR S&P 500 ETF
CTLT / Catalent, Inc.
PRME / Prime Medicine, Inc.
VTYX / Ventyx Biosciences, Inc.
IVVD / Invivyd, Inc.
NUVB / Nuvation Bio Inc.
STXS / Stereotaxis, Inc.
RPTX / Repare Therapeutics Inc.
KYMR / Kymera Therapeutics, Inc.
IMNM / Immunome, Inc.
IDYA / IDEAYA Biosciences, Inc.
ZYME / Zymeworks Inc.
BSX / Boston Scientific Corporation
REPL / Replimune Group, Inc.
STOK / Stoke Therapeutics, Inc.
ALVR / AlloVir, Inc.
ISRG / Intuitive Surgical, Inc.
BEAM / Beam Therapeutics Inc.
ATRA / Atara Biotherapeutics, Inc.
IGMS / IGM Biosciences, Inc.
HOOK / HOOKIPA Pharma Inc.
RAPT / RAPT Therapeutics, Inc.